If Walgreens Boots Alliance follows through with a sale to private equity, the company might join other healthcare deals ...

With 2024 nearing the end, Chief Financial Officer James Kehoe thought it was a good time to assess the state of Jacksonville-based FIS after its decision to shed Worldpay. “The company had become too ...

Pharmaceutical retailer Walgreens explores potential acquisition deal with private equity firm Sycamore Partners.

Albertsons, in its own announcement terminating the agreement on Wednesday, also said it had authorized a $2 billion stock buyback and hiked its quarterly cash dividend by 25%. The chain's biggest ...

To Skyler Weinand, chief investment officer at Regan Capital, the report “gives the Federal Reserve the green light for a 25 basis point rate cut at the December meeting, as it helps to confirm that ...

THE future of Boots has been plunged into uncertainty while a buyout fund negotiates with its US owner. Pharmacy giant Walgreens Boots Alliance, which bought Boots in 2014, is understood to be in ...

Walgreens Boots Alliance is considering selling the company to a private equity firm — a move that would take the publicly traded company private, according to a Wall Street Journal report.

The S&P 500 gained 0.8% on Wednesday, Dec. 11, 2024, as data showed inflation remaining sticky but matching forecasts, ...

The stock's fall snapped a three-day winning streak.

Customers have begun to worry about Walgreens' future following rumors of a potential sale to a private equity firm. Experts ...

Walgreens surges amid buyout rumors with Sycamore Partners, but doubts remain on deal feasibility and long-term prospects.

Walgreens has struggled lately due to declining prescription reimbursements and rising competition from Amazon and other ...